![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
* Premier expo by Informa Markets in India showcasing pharma ingredients, machinery, packaging, lab, and analytical services, slated for May 30-June 1 at Hitex, Hyderabad.
* Over 200 exhibitors, content rich conference and abundant networking prospects to service the 50 billion USD Indian pharma market to next level of growth
Hyderabad, May 22, 2024: PharmaLytica Expo, the flagship event within South India’s pharmaceutical industry, is eagerly approaching its milestone 10th edition, scheduled from May 30th to June 1st, 2024, at HITEX, Hyderabad a prominent pharmaceutical hub in India. Organised by Informa Markets in India, this event marks a decade of excellence, providing a vital business platform for showcasing the latest industry trends, innovations, and business opportunities across Pharma Machinery & Packaging, Lab Analytical & Cleanroom, and Pharma Ingredients segments.
Bringing together industry leaders, innovators, and stakeholders, PharmaLytica serves as a hub for exploring the forefront of India’s thriving pharmaceutical landscape. Participants will engage in valuable networking, fostering potential partnerships and collaborations amidst a targeted professional audience keen to take the pharmaceutical sector to the next level.
In its upcoming 10th edition, PharmaLytica 2024 anticipates the participation of more than 200 exhibitors showcasing more than 1000 brands from across the country, including major industry players such as Schneider Electric, Integrated Cleanroom Technology, Nicomac Taikisha Clean Rooms, HLE Glascoat Ltd, Scientific Research Instruments Company, Ami Polymer & many more. Furthermore, the event enjoys robust support from esteemed associations like BDMAI, FOPE and Telangana Life Sciences.
Speaking on the announcement of PharmaLytica 2024, Mr. Yogesh Mudras, Managing Director, Informa Markets India said, “We are delighted to embarked upon the decade long exciting journey of PharmaLytica, a path that has been dynamic, exciting, and nurtured the direction of the industry. As we scale up with passion and conviction, we recognize the pivotal role of this platform in nurturing industry direction.
The growth of India’s pharmaceutical and healthcare sectors within the Vikasit Bharat economic blueprint hinges on value-driven innovation and research, global supply chain integration, and equitable access. Noteworthy initiatives like the National Policy on Research and Development and Innovation in Pharma-MedTech Sector and the Ayushman Bharat programme are poised to enhance research capabilities and expand healthcare access. The substantial increase in governmental spending on pharmaceuticals, reaching Rs 90,658.63 crores in the interim Budget this year, an increase of 12.6 percent over the previous and the allocation of Rs. 1,000 crore for promoting bulk drug parks in FY25, underscores a commendable commitment to this cause. With a target of reaching US$450 billion by 2047, the industry will potentially fuel economic growth and employment opportunities, leveraging digital technologies such as data analytics and AI/ML to revolutionize R&D processes.
Under the vital umbrella of expos such as PharmaLytica, ideas flourish and businesses thrive, driving progress within the pharmaceutical landscape,” he added.
A Comprehensive and Engaging event
Renowned for introducing cutting-edge innovations and facilitating knowledge exchange, PharmaLytica, apart from the business on the show floor, will host conferences, digital marketplaces, targeted meeting places, seminars, and workshops led by industry experts. Reflecting current trends, regulatory issues, and policies, PharmaLytica 2024 will spotlight innovations, challenges, and future directions within the pharmaceutical sector. Key themes include the integration of digital technologies in healthcare, precision medicine, and sustainable practices, highlighting industry advancements and opportunities for growth.
An exclusive two-day conference, PharmaLytica 2024, with a theme of “Optimizing Pharmaceutical Quality and Compliance,” will bring together over 30 key industry figures for strategic discussions on the future of the pharmaceutical sector. To begin with, on day 1, experts will cover Technology Trends, Analytical Advancements, Impurities Assessment, Drugs Repositioning Strategies, Quality Integration in Clinical Development, Pharma Packaging and Machinery, and Analytical Instrumentation. Day 2 will explore trend and business opportunities and challenges in API, CRO, and CMO, Pharma Manufacturing, Innovation, Green Chemistry, Analytical Labs, Pharma Supply Chain, Cold Chain Management, and Industry Outlook related to Pharma Packaging, Labelling, Serialization, and Track and Trace. With renowned industry speakers, PharmaLytica 2024 ensures insightful discussions and valuable networking opportunities.
Hyderabad as a pharma hub:
Hyderabad holds a prominent position in the pharmaceutical sector, leading the nation in bulk drug manufacturing and ranking third in formulations. It contributes significantly to both domestic production and exports, accounting for 40% of India’s bulk drug production and 50% of its bulk drug exports. Termed as the ‘Bulk Drug Capital of India,’ Hyderabad’s pharmaceutical industry is valued at US$ 1.6 billion, with exports surpassing US$ 500 million. Forecasts suggest a promising annual growth rate of 20% for both the industry and exports.
The region comprising Telangana and Andhra Pradesh hosts over 2500 pharmaceutical companies. With more than 200 ‘Active Pharmaceutical Ingredients (API)’ units, the state anticipates annual growth rates of 10 to 15%. Hyderabad, often dubbed the ‘Vaccine Hub of India,’ houses leading vaccine producers. Additionally, the city has witnessed a surge in the clinical trial sector. The growth of Hyderabad as a pharmaceutical hub can be attributed to factors like the establishment of Indian Drugs and Pharmaceuticals Ltd. (IDPL) and the entrepreneurial spirit of its populace, complemented by a skilled talent pool and conducive infrastructure.
